Exclusive: The heart-wrenching story of a mother's battle to save her daughter, Arianna, from the ultra-rare GRIN1 gene mutation, a condition so uncommon it affects just a handful of people globally.
Groundbreaking medical research from UCL and University College London Hospitals has successfully lowered levels of the toxic protein that causes Huntington's disease using an innovative genetic therapy injected into the spinal fluid.
Leading doctors warn that current NHS risk calculators are failing Black men, who face double the prostate cancer risk. New recommendations call for urgent screening protocol reforms.
Groundbreaking research reveals that any alcohol consumption, no matter how moderate, increases your chances of developing over 60 medical conditions including heart disease and diabetes.
Former US President Donald Trump has sparked fresh controversy by suggesting a link between acetaminophen use in pregnancy and autism, citing a single study. We examine the claims and the scientific evidence.
UK scientists pioneer a revolutionary vaccine targeting Candida albicans, a deadly fungal infection, offering a potential shield for vulnerable patients and a new weapon against antimicrobial resistance.
Liberal Democrat leader Sir Ed Davey proposes a 'brain gain' for the NHS, urging the government to actively recruit American cancer researchers facing severe funding cuts under a potential second Trump administration.
New research reveals that GLP-1 based weight loss medications like Ozempic may cause unforeseen changes to pancreas cells, raising important safety questions for millions of users worldwide.
Exclusive investigation reveals US government agency sanctioned controversial experiments transplanting human foetal tissue into lab animals, sparking fierce ethical debate.
A looming US government shutdown threatens to sever critical healthcare funding, jeopardising medical services for millions of vulnerable Americans and creating chaos for federal health agencies.
Groundbreaking UK research reveals high blood pressure and type 2 diabetes significantly increase deadly liver disease risk, offering new prevention strategies for millions.
A landmark study suggests a daily low-dose aspirin could dramatically reduce the risk of colorectal cancer returning, offering new hope for thousands of NHS patients.
Former chief scientific adviser Sir Patrick Vallance warns that dwindling investment in medical research and innovation threatens the future of the NHS and patient care. Discover the urgent call for action.
A groundbreaking digital cognitive test, developed by UK researchers, uses AI and eye-tracking to detect Alzheimer's years before symptoms appear, offering a rapid and accessible alternative to traditional methods.
Groundbreaking UK research reveals a simple blood test could predict your risk of type 2 diabetes and severe liver disease years in advance by analysing gut microbiome molecules. Discover how this medical revolution could transform preventative healthcare
A groundbreaking new vaccine against colorectal cancer, developed by Russian scientists, has been declared safe and effective in early trials, offering a beacon of hope for millions worldwide.
In a historic move, King Charles III has agreed to transform part of his former London residence, Clarence House, into a new state-of-the-art health centre for Imperial College London, continuing a legacy of royal support for medical research.
New research from top universities shows dramatic lifespan extension is possible through targeted interventions. Discover the science behind living longer and healthier.
A groundbreaking study from the University of Cambridge reveals that a widely prescribed blood pressure medication could dramatically reduce dementia risk and slow cognitive decline in Alzheimer's patients, offering new hope for millions.
A groundbreaking blood test developed in the UK can detect the toxic tau protein associated with Alzheimer's disease with 97% accuracy, paving the way for earlier diagnosis and treatment.
New research exposes a critical gap in the UK's health awareness, with Britons less likely to identify key diabetes symptoms compared to European neighbours. Experts warn this knowledge gap could lead to dangerous delays in diagnosis and treatment.
Groundbreaking medical research reveals a new anti-inflammatory drug shows no significant advantage over traditional aspirin for heart attack prevention in most patients, challenging pharmaceutical expectations.
Groundbreaking research presented at Madrid's cardiology conference reveals a new AI-powered heart scan that detects hidden conditions years earlier, potentially saving thousands of lives annually through early intervention.
Groundbreaking research from the UK reveals a specific brain cell that controls hunger impulses, paving the way for revolutionary obesity prevention and treatment strategies that could transform public health.
UK researchers are exploring a revolutionary 'microdosing' strategy for powerful weight-loss medications like Wegovy, potentially slashing costs and side effects while boosting accessibility for NHS patients.
Groundbreaking UK research reveals how the body's natural process for creating proteins becomes 'clogged', leading to the motor neurone damage seen in MND, opening new avenues for treatment.
A revolutionary study from the University of Cambridge and NHS researchers uncovers a direct link between a widespread, typically benign virus and the development of Parkinson's disease, potentially transforming our understanding of the neurological condi
Exclusive investigation reveals how political interference, budget cuts, and a brain drain of top scientists are pushing American health agencies toward collapse, risking future pandemic responses.
Groundbreaking NHS research shows clopidogrel is significantly more effective than traditional aspirin at preventing recurrent heart attacks and strokes, potentially transforming cardiovascular treatment protocols across Britain.
Groundbreaking research finds beta-blockers significantly improve survival rates and reduce heart failure in women post-heart attack, challenging previous assumptions about gender-neutral treatment efficacy.